Literature DB >> 1894632

Entry of diphtheria toxin-protein A chimeras into cells.

I H Madshus1, H Stenmark, K Sandvig, S Olsnes.   

Abstract

Fusion proteins consisting of diphtheria toxin and a duplicated Fc-binding domain of protein A were made in vitro after amplification of the DNA template by the polymerase chain reaction. The fusion proteins bound avidly to Vero cells coated with antibodies. A fusion protein containing full-length diphtheria toxin was toxic at lower concentrations than diphtheria toxin alone, apparently due to more efficient binding. The enzymatic part of the fusion protein was translocated across the surface membrane upon exposure to low pH. Like authentic diphtheria toxin, the fusion protein formed cation selective channels at low pH. Excess amounts of unlabeled diphtheria toxin inhibited formation of pronase-protected fragments derived from radiolabeled fusion protein. Furthermore, conditions that down-regulate the diphtheria toxin receptors reduced the sensitivity of the cells to the fusion protein, supporting the notion that authentic diphtheria toxin receptors are required. At temperatures below 18 degrees C the toxicity of the fusion protein was strongly reduced, whereas there was no temperature block for authentic diphtheria toxin. Brefeldin A protected Vero cells against the fusion protein but not against diphtheria toxin. The results indicate that the diphtheria toxin receptor is required for efficient toxin translocation even under conditions where the toxin is bound by an alternate binding moiety, and they suggest that the intracellular routing of the fusion protein is different from that of diphtheria toxin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894632

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein.

Authors:  T J Goletz; K R Klimpel; N Arora; S H Leppla; J M Keith; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  Membrane translocation of diphtheria toxin carrying passenger protein domains.

Authors:  I H Madshus; S Olsnes; H Stenmark
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Pertussis toxin-mediated ADP-ribosylation of target proteins in Chinese hamster ovary cells involves a vesicle trafficking mechanism.

Authors:  Y Xu; J T Barbieri
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

Review 4.  Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases.

Authors:  V M Gordon; S H Leppla
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

5.  Cellular uptake of the Clostridium perfringens binary iota-toxin.

Authors:  D Blöcker; J Behlke; K Aktories; H Barth
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin.

Authors:  M Varughese; A V Teixeira; S Liu; S H Leppla
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

7.  Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies.

Authors:  M Varughese; A Chi; A V Teixeira; P J Nicholls; J M Keith; S H Leppla
Journal:  Mol Med       Date:  1998-02       Impact factor: 6.354

Review 8.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

Review 9.  Clostridium and bacillus binary enterotoxins: bad for the bowels, and eukaryotic being.

Authors:  Bradley G Stiles; Kisha Pradhan; Jodie M Fleming; Ramar Perumal Samy; Holger Barth; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2014-09-05       Impact factor: 4.546

10.  Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol.

Authors:  Sebastian Heber; Lara Barthold; Jan Baier; Panagiotis Papatheodorou; Giorgio Fois; Manfred Frick; Holger Barth; Stephan Fischer
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.